Kura Oncology (KURA) News Today → AI Hell Will Break Loose [June 30, 2024] … (From Banyan Hill Publishing) (Ad) Free KURA Stock Alerts $22.06 +0.27 (+1.24%) (As of 06/6/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 5 at 10:29 AM | marketbeat.comAffinity Asset Advisors LLC Lowers Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Affinity Asset Advisors LLC lowered its holdings in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 77.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 191,535 shares of the company's stock after sJune 3, 2024 | marketbeat.comDimensional Fund Advisors LP Has $28.79 Million Position in Kura Oncology, Inc. (NASDAQ:KURA)Dimensional Fund Advisors LP increased its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 10.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,001,754 shares of theMay 29, 2024 | globenewswire.comKura Oncology to Participate in Jefferies Global Healthcare ConferenceMay 28, 2024 | marketbeat.comFranklin Resources Inc. Acquires 130,710 Shares of Kura Oncology, Inc. (NASDAQ:KURA)Franklin Resources Inc. boosted its holdings in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 10.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,353,665 shares of the company's stock after pMay 25, 2024 | finance.yahoo.comKura Oncology, Inc. (KURA)May 21, 2024 | insidertrades.comKura Oncology, Inc. (NASDAQ:KURA) Insider Teresa Brophy Bair Sells 2,615 SharesMay 20, 2024 | marketbeat.comTeresa Brophy Bair Sells 2,615 Shares of Kura Oncology, Inc. (NASDAQ:KURA) StockKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) insider Teresa Brophy Bair sold 2,615 shares of the firm's stock in a transaction on Monday, May 20th. The shares were sold at an average price of $22.15, for a total transaction of $57,922.25. Following the completion of the transaction, the insider now owns 68,979 shares in the company, valued at $1,527,884.85. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.May 19, 2024 | msn.comInvestor Enthusiasm Soars for Kura Oncology (NASDAQ:KURA)May 19, 2024 | marketbeat.comKura Oncology, Inc. (NASDAQ:KURA) Receives Average Rating of "Moderate Buy" from AnalystsKura Oncology, Inc. (NASDAQ:KURA - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the companMay 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kura Oncology Amidst Positive Developments and Strong Trial ProgressMay 16, 2024 | marketbeat.comKura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by JMP SecuritiesJMP Securities reissued a "market outperform" rating and set a $32.00 price target on shares of Kura Oncology in a report on Thursday.May 16, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kura Oncology Amidst Promising Ziftomenib Trials and Strategic AdvantagesMay 14, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Tourmaline Bio (TRML)May 14, 2024 | marketbeat.comKura Oncology (NASDAQ:KURA) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reiterated a "buy" rating and set a $32.00 price target on shares of Kura Oncology in a report on Tuesday.May 14, 2024 | globenewswire.comKura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AMLMay 8, 2024 | globenewswire.comKura Oncology to Participate in Bank of America Securities Healthcare ConferenceMay 7, 2024 | seekingalpha.comKura Oncology: Balancing Act Of Promise And PragmatismMay 6, 2024 | finance.yahoo.comKura Oncology, Inc. (NASDAQ:KURA) Q1 2024 Earnings Call TranscriptMay 6, 2024 | marketbeat.comJMP Securities Reiterates Market Outperform Rating for Kura Oncology (NASDAQ:KURA)JMP Securities reissued a "market outperform" rating and issued a $32.00 price target on shares of Kura Oncology in a report on Monday.May 3, 2024 | finanznachrichten.deKura Oncology, Inc.: Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 3, 2024 | chron.comKura Oncology: Q1 Earnings SnapshotMay 3, 2024 | finance.yahoo.comKura Oncology Inc (KURA) (Q1 2024) Earnings Call Transcript Highlights: Key Financial and ...May 3, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kura Oncology Amid Strong Financials and Promising Clinical MilestonesMay 3, 2024 | marketbeat.comKura Oncology's (KURA) "Buy" Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and set a $32.00 price objective on shares of Kura Oncology in a research report on Friday.May 3, 2024 | marketbeat.comKura Oncology (NASDAQ:KURA) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPSKura Oncology (NASDAQ:KURA - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.59) earnings per share for the quarter, missing analysts' consensus estimates of ($0.56) by ($0.03). During the same period in the previous year, the company posted ($0.50) EPS. The firm's revenue was up .0% on a year-over-year basis.May 3, 2024 | globenewswire.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 2, 2024 | investorplace.comKURA Stock Earnings: Kura Oncology Misses EPS for Q1 2024May 2, 2024 | msn.comKura Oncology Q1 2024 Earnings PreviewMay 2, 2024 | finance.yahoo.comKura Oncology Reports First Quarter 2024 Financial ResultsMay 2, 2024 | globenewswire.comKura Oncology Reports First Quarter 2024 Financial ResultsApril 26, 2024 | marketbeat.comKura Oncology (KURA) Scheduled to Post Quarterly Earnings on ThursdayKura Oncology (NASDAQ:KURA) will be releasing earnings after the market closes on Thursday, May 2, Zacks reports.April 25, 2024 | globenewswire.comKura Oncology to Report First Quarter 2024 Financial ResultsApril 24, 2024 | uk.investing.comFDA grants breakthrough status for Kura Oncology's AML drug candicateApril 23, 2024 | finanznachrichten.deKura Oncology, Inc.: Kura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AMLApril 22, 2024 | markets.businessinsider.comKura Oncology’s Buy Rating Affirmed by Analyst Joseph Pantginis Amid Breakthrough Therapy Designation and Promising Preclinical DataApril 22, 2024 | marketbeat.comKura Oncology (NASDAQ:KURA) Rating Reiterated by HC WainwrightHC Wainwright restated a "buy" rating and set a $32.00 price objective on shares of Kura Oncology in a research note on Monday.April 22, 2024 | marketbeat.comKura Oncology (NASDAQ:KURA) Shares Gap Up to $17.53Kura Oncology (NASDAQ:KURA) Shares Gap Up to $17.53April 22, 2024 | markets.businessinsider.comKura Oncology Gets FDA Breakthrough Therapy Designation For Ziftomenib In R/R NPM1-Mutant AMLApril 22, 2024 | marketwatch.comKura Oncology Gets Breakthrough Designation For Leukemia TherapyApril 22, 2024 | finance.yahoo.comKura Oncology Receives Breakthrough Therapy Designation for Ziftomenib in NPM1-Mutant AMLApril 15, 2024 | marketbeat.comStockNews.com Downgrades Kura Oncology (NASDAQ:KURA) to SellStockNews.com lowered Kura Oncology from a "hold" rating to a "sell" rating in a research report on Monday.April 15, 2024 | marketbeat.comDekaBank Deutsche Girozentrale Buys 65,000 Shares of Kura Oncology, Inc. (NASDAQ:KURA)DekaBank Deutsche Girozentrale raised its stake in Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 216.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 95,000 shares of the company's stock after purchasing an additional 65,000 shares during the quarter.April 11, 2024 | marketbeat.comVanguard Group Inc. Increases Stock Holdings in Kura Oncology, Inc. (NASDAQ:KURA)Vanguard Group Inc. lifted its stake in shares of Kura Oncology, Inc. (NASDAQ:KURA - Free Report) by 7.5% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 3,924,448 shares of the company's stock after buying an additional 275,173 shares durApril 10, 2024 | msn.comImmunotherapy After Definitive Therapy Flops in Head and Neck CancerApril 10, 2024 | nasdaq.comValidea Detailed Fundamental Analysis - KURAApril 10, 2024 | globenewswire.comKura Oncology to Participate in Stifel Targeted Oncology ForumApril 10, 2024 | globenewswire.comKura Oncology to Participate in Stifel Targeted Oncology ForumApril 5, 2024 | globenewswire.comKura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 3, 2024 | marketbeat.comKura Oncology (NASDAQ:KURA) Upgraded to "Hold" by StockNews.comStockNews.com upgraded shares of Kura Oncology from a "sell" rating to a "hold" rating in a research note on Wednesday.March 28, 2024 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Buy Rating on Celcuity (CELC) Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address The only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. KURA Media Mentions By Week KURA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KURA News Sentiment▼1.740.73▲Average Medical News Sentiment KURA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KURA Articles This Week▼24▲KURA Articles Average Week Get Kura Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for KURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: XNCR News IRWD News ZNTL News ZYME News IGMS News PRLD News VKTX News IONS News OGN News MDGL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KURA) was last updated on 6/7/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredElon Musk’s Final Masterpiece: “X-9840”The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Ju...Paradigm Press | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored